Klor-con M20

   
Google
 
Web NewDrugInformation.com

Klor-con M20


Drug - Klor-con M20
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Potassium Chloride
Multiple ingredients are in alphabetical order.

Strength - 20MEQ
The potency of the active ingredient(s), Potassium Chloride. May repeat for multiple part products.

Applicant - UPSHER SMITH
The firm name holding legal responsibility for Klor-con M20. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074726
The FDA assigned number to Klor-con M20. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Klor-con M20. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 20, 1998
The date Klor-con M20 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Klor-con M20. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Klor-con M20 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Upsher Smith Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Klor-con M20.

Klor-con M20